Stay informed on our latest MOS 503B updates and compounded drug availability at www.mcguff.com/503Bupdate
doi: 10.1186/s12891-022-05396-5 Summary Keywords type 2 diabetes, osteoporosis, GLP-1 receptor agonists, electronic medical records, cohort study, bone metabolism, fracture risk Citation Chen M, Lyu Y, Zhao J, Han X, Huang T, Yang T and Zhou Y (2025) Use of GLP-1 receptor agonist and risk of osteoporosis among patients with type 2 diabetes: a real-world study
Individualized decision-making with your physician is essential
(Pun absolutely intended.) Your Gut & Poop Qs, Answered Q: Do I need both Flatter Me and the GLP-1 Fiber Booster
The GLOW stack is a community-derived blend of GHK-Cu, BPC-157, and TB-500 used for combined skin and recovery research
What labs should you monitor on Cagrilintide